Infectious Disease Alert – October 1, 2017
October 1, 2017
View Issues
-
Extreme Weather and Infectious Diseases: What Will Follow Hurricanes Harvey and Irma?
Among the dangers faced after a severe weather event is an increased risk of various infections.
-
Chagas Seroprevalence in Military Personnel in Texas
A cross-sectional study of military trainees and instructors who spend significant time in field conditions was performed at Joint Base San Antonio to determine the prevalence of Trypanosoma cruzi infection. None tested positive by polymerase chain reaction nor by enzyme-linked immunosorbent assay or indirect immunofluorescent antibody.
-
Rheumatic Heart Disease — The Global Situation
With advances in access to good medical care, the global burden of rheumatic heart disease is declining. However, there still is significant disease in resource-limited regions of the world.
-
Fungal Endophthalmitis: Another Risk Associated With Intravenous Drug Use
A retrospective cohort study found that endogenous fungal endophthalmitis is associated with intravenous drug use and frequently results in poor visual outcomes despite appropriate surgical and antifungal therapy.
-
Delafloxacin (Baxdela®)
Delafloxacin is a new broad-spectrum fluoroquinolone that was approved by the U.S. Food and Drug Administration in June 2017 for acute bacterial skin and skin structure infections.
-
California and Coccidioidomycosis: Be Careful About the Air You Breathe
Cases of coccidioidomycosis significantly increased in 2016.
-
Infectious Disease Alert Updates
Corporate Antibiotic Stewardship; Hypervirulence Meets Antibiotic Resistance — A Lethal Combination; Glue Masquerading as an Aortic Root Abscess; Molecular Diagnostic Coup